首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein expressed in Pichia pastoris.
【24h】

Preparation and characterization of a potent, long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein expressed in Pichia pastoris.

机译:巴斯德毕赤酵母中表达的强效,持久的重组人血清白蛋白-干扰素-α2b融合蛋白的制备和表征。

获取原文
获取原文并翻译 | 示例
           

摘要

A long-lasting recombinant human serum albumin-interferon-alpha2b fusion protein (rHSA/IFNalpha2b) was prepared and its structure and biological activities were studied. rHSA/IFNalpha2b was expressed in methylotrophic yeast Pichia pastoris with HSA's natural signal peptide and purified by dye affinity chromatography, hydrophobic interaction chromatography, ion exchange chromatography and Sephadex G25. Purity of the prepared rHSA/IFNalpha2b was greater than 97% analyzed by non-reduced SDS-PAGE and RP-HPLC. Structure and biological activities of the prepared rHSA/IFNalpha2b were characterized by physical, chemical and biological methods. Its pI was 5.3 and showed a single band on IEF gel. Molecular weight determined by MALDI-TOF was 86004.3+/-29.2. Amino-terminal and carboxyl-terminal amino acid sequences were identical to predicted sequence. Its specific activity in vitro was 6.3+/-0.8x10(5) IU/mg fusion protein, retaining about 1.4% of that of unmodified rIFNalpha on a molar basis. After administered in monkeys, significant increases of 2',5'-oligoadenylate synthetase activity relative to IFN-alpha were maintained for 14 days in serum and the rHSA/IFNalpha2b showed more potent biological activity than IFN-alpha on a molar basis. Therefore, markedly improved in vivo biological activity of rHSA/IFNalpha2b could exhibit more potent antiviral activity than IFNalpha2b in future clinical trials.
机译:制备了长效重组人血清白蛋白-干扰素-α2b融合蛋白(rHSA / IFNalpha2b),并对其结构和生物学活性进行了研究。 rHSA / IFNalpha2b在带有HSA天然信号肽的甲基营养酵母巴斯德毕赤酵母中表达,并通过染料亲和色谱,疏水相互作用色谱,离子交换色谱和Sephadex G25纯化。通过未还原的SDS-PAGE和RP-HPLC分析,所制备的rHSA /IFNα2b的纯度大于97%。通过物理,化学和生物学方法表征了制备的rHSA /IFNα2b的结构和生物学活性。它的pI为5.3,并在IEF凝胶上显示一条条带。通过MALDI-TOF测定的分子量为86004.3 +/- 29.2。氨基末端和羧基末端的氨基酸序列与预测的序列相同。其体外比活为6.3 +/- 0.8x10(5)IU / mg融合蛋白,按摩尔计保留未修饰的rIFNalpha的约1.4%。在猴子中给药后,血清中2',5'-寡腺苷酸合成酶活性相对于IFN-α的显着增加保持了14天,而rHSA / IFNalpha2b在摩尔基础上显示出比IFN-α更有效的生物学活性。因此,在未来的临床试验中,rHSA / IFNalpha2b的体内生物学活性得到显着改善,可能比IFNalpha2b表现出更强的抗病毒活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号